Skip to content

Strategy

US · MSTR #396 by market cap Listed 1970
77.80 -8.33 -9.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 86.10 -0.03%
After-hours 79.50 +2.19%
Overnight 85.60 -0.62%
168.5077.8077.802026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on MSTR?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -43.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 6.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall D+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B-

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 2.8x Better than 100%
Price / Sales 66.4x Better than 4%
Growth D

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -1.5% Better than 19%
Net income CAGR (3Y) -28.1% Better than 12%
Free cash flow CAGR (3Y) -22.3% Better than 17%
Profitability C-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 68.7% Better than 82%
Operating margin -8.6% Better than 15%
Net margin -886.3% Better than 3%
Return on equity -13.6% Better than 18%
Return on invested capital -10.8% Better than 17%
Momentum D

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -34.8% Better than 14%
6-month return -51.3% Better than 7%
12-month return (ex latest month) -14.5% Better than 18%
Distance below 52-week high 60.8% Better than 10%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 5.6x Better than 88%
Debt to assets 13.4% Better than 64%
Interest coverage -84.1x Better than 5%
Free cash flow / net income 147.5% Better than 65%
Analyst View A+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 92.3% Better than 75%
Upside to average target 192.7% Better than 94%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -30.30%
1M -45.49%
3M -30.78%
6M -53.08%
YTD -48.80%
1Y -56.08%
3Y +52.99%
5Y +8.31%

Key statistics

Price & volume

Prev close
86.13
Open
86.31
Day range
77.69 - 87.95
Avg price
80.87
Volume
35.91M
Turnover
2.90B
Amplitude
11.91%
52-week range
77.69 - 198.40

Valuation

P/E
-5.11
P/E (TTM)
-1.58
P/B
0.59
EPS
-15.23
Net profit
-6.43B
Net assets
55.44B

Share structure

Market cap
32.86B
Float cap
31.26B
Shares out
422.35M
Float shares
401.76M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 0% of range
77.69 198.40

60.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-183.51M net over the window

Short interest

Shares short
26.82M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Strategy (MSTR)?

Strategy last traded at 77.80. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Strategy's market cap?

About 32.86B.

What is the P/E ratio of Strategy?

The trailing twelve-month P/E is -1.58. The Valuation tab shows it against the stock's own five-year range.

Does Strategy pay a dividend?

Strategy does not currently pay a regular dividend.

Is Strategy a buy according to analysts?

The consensus of 13 analysts is a Buy rating, with an average 12-month price target of 222.92, which implies 186.5% upside from the current price. This is not investment advice.

What is Strategy's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Strategy a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Strategy discussion 0 comments

Add a comment